A bill for an act relating to the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or other print disability. (Formerly HF 2033.) Effective date: 07/01/2026.
HF 2585 requires the Iowa Board of Pharmacy to adopt rules ensuring that, by January 1, 2027, pharmacies provide accessible prescription-related information to people who are blind, have a visual impairment, or have other print disabilities when requested. The required accessible materials include prescription drug labels, bag tags, and medical guides, and pharmacies may either provide the accessibility measures directly or refer the person to another pharmacy that does. The bill also requires that these services be provided at no additional cost and, after a reasonable development period, in a format that is fully accessible within a timeframe comparable to that for customers without disabilities.
The bill applies broadly to pharmacies dispensing prescription drugs in Iowa, but it excludes institutional pharmacies in hospitals, nursing homes, and long-term care facilities; pharmacies participating in drug donation repository programs when dispensing donated drugs; and pharmacies located in jails, correctional institutions, or juvenile detention homes. It also directs the Board of Pharmacy to publish an annual list of pharmacies offering these accessibility measures and to seek input from affected individuals when writing the rules. The board must also ensure the rules align with federal guidance and industry standards and include public notice about the availability of accessible and audio-format prescription information. A report on implementation and further recommendations is due to the governor and legislature by January 1, 2028.
The bill adds a new section to Iowa Code chapter 155A governing pharmacy practice and accessibility obligations. It creates a regulatory mandate for the Board of Pharmacy to establish standards for accessible prescription labels, bag tags, and medical guides, and it imposes compliance expectations on pharmacies statewide, subject to specified exemptions. The measure also creates a reporting requirement for the board, which may inform future legislative or administrative changes.
The available voting history shows strong, unanimous support in both chambers, with no recorded opposition in the House or Senate votes. That pattern suggests the bill was broadly viewed as a practical accessibility measure and a noncontroversial consumer protection for people with disabilities. The absence of committee transcript material limits more detailed insight into debate, but the final votes indicate clear bipartisan agreement.
No significant contention is evident in the available record. The main policy choices in the bill are the scope of pharmacy coverage, the exemptions for institutional, donation-program, and correctional-facility pharmacies, and the requirement that accessibility be provided at no additional cost after a reasonable development period. If any concerns were raised, they are not reflected in the provided transcripts or voting record, and the unanimous votes suggest any issues were resolved before final passage.